The other targets of alcohol use disorder: The systemic effects of alcohol abuse


Drinking alcohol is an established and normalised practice in our society, even though it can physically harm us. High-risk alcohol drinking patterns can increase the chance of negative consequences for the drinkers or their environment. The liver is by far the organ most affected by alcohol abuse; however, alcohol use disorder is a systemic disease which affects a wide range of organs and psychological processes. Other systems that can be affected by continued alcohol consumption include the immune, neurological, and cardiovascular systems. In addition, alcohol can lead to epigenetic alterations that may be transmitted from one generation to the next.


alcohol use disorder; immunity; neurological damage; cardiovascular system; epigenetics

Full Text:



Anstee, Q. M., Daly, A. K., & Day, C. P. (2015). Genetics of alcoholic liver disease. Seminars in Liver Disease, 35(04), 361–374.

Berkel, T. D. M., & Pandey, S. C. (2017). Emerging role of epigenetic mechanisms in alcohol addiction. Alcoholism: Clinical and Experimental Research, 41, 666–680.

Carrigan, M. A., Uryasev, O., Frye, C. B., Eckman, B. L., Myers, C. R., Hurley, T. D., & Benner, S. A. (2015). Hominids adapted to metabolize ethanol long before human-directed fermentation. Proceedings of the National Academy of Sciences of the United States of America, 112(2), 458–463.

Cederbaum, A. I. (2012). Alcohol metabolism. Clinics in Liver Disease, 16(4), 667–685.

Chamorro, A. J., Rosón-Hernández, B., Medina-García, J.-A., Muga-Bustamante, R., Fernández-Solá, J., Martín-González, M.-C., Seco-Hernández, E., Novo-Veleiro, I., Suárez-Cuervo, C., Mateos-Díaz, A. M., Monte-Secades, R., Machado-Prieto, B., Puerta-Louro, R., Prada-González, C., Fernández-Rial, Á., Sabio-Repiso, P., Vázquez-Vigo, R., Antolí-Royo, A.-C., Gomila-Grange, A., … Laso, F.-J. (2017). Differences between alcoholic and nonalcoholic patients with Wernicke encephalopathy: A multicenter observational study. Mayo Clinic Proceedings, 92(6), 899–907.

Degenhardt, L., Charlson, F., Ferrari, A., Santomauro, D., Erskine, H., Mantilla-Herrara, A., Whiteford, H., Leung, J., Naghavi, M., Griswold, M., Rehm, J., Hall, W., Sartorius, B., Scott, J., Vollset, S. E., Knsudse, A. K., Haro, J. M., Patton, G., Kopec, J., … Vos, T. (2018). The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: A systematic analysis for the Global Burden of Disease Study 2016. The Lancet Psychiatry, 5(12), 987–1012.

García-Calvo, X., Bolao, F., Sanvisens, A., Zuluaga, P., Tor, J., Muga, R., & Fuster, D. (2020). Significance of markers of monocyte activation (CD163 and sCD14) and inflammation (IL-6) in patients admitted for alcohol use disorder treatment. Alcoholism: Clinical and Experimental Research, 44(1), 152–158.

Leger, A. S. S., Cochrane, A. L., & Moore, F. (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. The Lancet, 313(8124), 1017–1020.

Observatorio Español de las Drogas y las Adicciones. (2020). INFORME 2020 Alcohol, tabaco y drogas ilegales en España.

Rao, R., & Topiwala, A. (2020). Alcohol use disorders and the brain. Addiction, 115(8), 1580–1589.

Sanvisens, A., Zuluaga, P., Rivas, I., Rubio, G., Gual, A., Torrens, M., Short, A., Álvarez, F. J., Tor, J. Farré, M., Rodríguez de Fonseca, F., & Muga, R. (2017). Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study. Adicciones, 30(4), 931.

Szabo, G., & Saha, B. (2015). Alcohol’s effect on host defense. Alcohol Research: Current Reviews, 37(2), 159–170.

Wood, A. M., Kaptoge, S., Butterworth, A., Willeit, P., Warnakula, S., Bolton, T., Paige, E., Paul, D. S., Sweeting, M., Burgess, S., Bell, S., Astle, W., Stevens, D., Koulman, A., Selmer, R. M., Verschuren, W. M. M., Sato, S., Njølstad, I., Woodward, M., … Danesh, J. (2018). Risk thresholds for alcohol consumption: Combined analysis of individual-participant data for 599 912 current drinkers in 83 prospective studies. The Lancet, 391(10129), 1513–1523.

Zuluaga, P., Sanvisens, A., Teniente-Serra, A., El Ars, O., Fuster, D., Quirant-Sánchez, B., Martínez-Cáceres, E., & Muga, R. (2020). Loss of naive T lymphocytes is associated with advanced liver fibrosis in alcohol use disorder. Drug and Alcohol Dependence, 213, 108046.


  • There are currently no refbacks.

Creative Commons License
Texts in the journal are –unless otherwise indicated– published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License


Creative Commons License
Texts in the journal are –unless otherwise indicated– published under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License